Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat

Enza Palazzo1, Rita Genovese, Loredana Mariani

  • 1Department of Experimental Medicine, Section of Pharmacology "L. Donatelli", Faculty of Medicine and Surgery, II University of Naples, via Costantinopoli 16, 80138 Naples, Italy. enza.palazzo@unina2.it

Insights

Blocking peripheral metabotropic glutamate 5 (mGlu5) receptors with MPEP reduced inflammatory pain and dorsal raphe serotonin (5-HT) increases. This suggests peripheral mGlu5 receptors play a key role in inflammatory pain signaling.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Inflammatory pain conditions often involve altered serotonin (5-HT) neurotransmission.
  • Metabotropic glutamate subtype 5 (mGlu5) receptors are implicated in pain modulation.

Purpose of the Study:

  • To investigate the role of peripheral and central mGlu5 receptor antagonism by MPEP on dorsal raphe 5-HT activity and thermal hyperalgesia in inflammatory pain models in rats.

Main Methods:

  • Induction of inflammatory pain using formalin and carrageenan injections in rats.
  • Administration of MPEP via systemic (i.p.), dorsal raphe (microdialysis), and peripheral (hind paw) routes.
  • Measurement of dorsal raphe 5-HT levels and thermal nociceptive threshold.

Main Results:

  • Systemic and peripheral MPEP administration enhanced formalin/carrageenan-induced 5-HT increases and reduced thermal hyperalgesia.
  • Intra-dorsal raphe MPEP did not alter 5-HT levels or thermal hyperalgesia.
  • Peripheral MPEP administration attenuated the increase in dorsal raphe serotonergic neurons and reversed thermal hyperalgesia.

Conclusions:

  • Peripheral mGlu5 receptor blockade is effective in mitigating inflammatory pain and associated hyperactivation of dorsal raphe serotonergic neurons.
  • Targeting peripheral mGlu5 receptors represents a potential therapeutic strategy for inflammatory pain.

Related Concept Videos